Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://montylpmi355097.bloguerosa.com/37766754/retaglutide-a-promising-glp-1-receptor-agonist